The new version of the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, which takes effect on July 1, requires drugmakers to provide more details about their relationships ...

More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...

ABPI’s recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content ...

The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical ...

The Association of the British Pharmaceutical Industry (ABPI) has launched its 2021 Code of Practice to help companies operate to high ethical standards. The ABPI Code of Practice is the industry’s ...

Novo Nordisk has been suspended from the Association of the British Pharmaceutical Industry (ABPI) due to what the organisation describes as ‘serious breaches’ of its code of practice. The decision ...

Is it a coincidence that the ABPI has netted a whole shoal of conduct contraveners in the first month its amended Code of Practice became operational? Is it a coincidence that the ABPI has netted a ...

GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd and ProStraken Group plc have been named and publicly shamed for breaching the Association of the British Pharmaceutical Industry's (ABPI) Code of ...

After Novo Nordisk breached not one, not two, but seven clauses of the code that regulates U.K. drugmakers, its U.K. general manager is stepping down as president of the industry's national ...

The new Code has been updated to reflect changes in the pharma environment The Association of the British Pharmaceutical Industry (ABPI) has launched its new Code of Practice, containing updated ...

GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd, and ProStraken Group plc have been accused of breaching the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice.